HBK Investments’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-248,195
Closed -$2.98M 1383
2018
Q2
$2.98M Buy
248,195
+85,268
+52% +$1.05M 0.02% 389
2018
Q1
$2.01M Buy
+162,927
New +$2.31M 0.01% 448
2017
Q2
Sell
-109,132
Closed -$1.38M 1046
2017
Q1
$1.38M Sell
109,132
-166,668
-60% -$1.98M 0.01% 381
2016
Q4
$2.82M Buy
275,800
+214,900
+353% +$2.45M 0.03% 286
2016
Q3
$802K Sell
60,900
-131,300
-68% -$1.76M 0.01% 559
2016
Q2
$2.44M Buy
192,200
+170,600
+790% +$2.26M 0.02% 371
2016
Q1
$285K Buy
+21,600
New +$284K ﹤0.01% 838
2014
Q4
Sell
-65,900
Closed -$884K 1165
2014
Q3
$884K Buy
65,900
+17,300
+36% +$262K 0.01% 588
2014
Q2
$780K Buy
+48,600
New +$758K 0.02% 579

Other funds holding MDRX

HBK Investments's MDRX Position: Q3 2018 in Review

HBK Investments sold out of Veradigm Inc. Common Stock (MDRX) in Q3 2018, closing a stake of 248,195 shares — an estimated $2.98M sold.

HBK Investments first reported a position in MDRX in Q2 2014 and held it in 9 quarters. The position peaked at $2.98M in Q2 2018. 253 funds tracked by Wall St. Rank hold MDRX as of Q3 2018.

  • HBK Investments reported no remaining Veradigm Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • HBK Investments sold 248,195 Veradigm Inc. Common Stock shares in Q3 2018, an estimated $2.98M.
  • HBK Investments first reported a position in Veradigm Inc. Common Stock in Q2 2014 and held it in 9 quarters.
  • HBK Investments's Veradigm Inc. Common Stock position peaked at $2.98M in Q2 2018.
  • 253 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q3 2018.

Based on HBK Investments's 13F filing for Q3 2018, filed 14 Nov 2018.